from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1943c/mazE5

LFCtreatmentdescriptionclass of inhibitor

1.492

Amikacinug/mL Amikacintranslation

1.954

Cap5-10ug/mL Capreomycintranslation

2.285

Rox10-50 ug/mL Roxithromycintranslation

1.946

SM2-5 ug/mL Streptomycintranslation

2.463

Tet5-10 ug/mL Tetracyclinetranslation

-0.373

Rif0.2-5ug/mL Rifampicintranscription

0.056

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.689

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.180

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.476

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.547

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.374

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.163

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.848

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.397

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.479

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.590

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.835

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.314

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.479

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.313

KCN5-20 ug/mL Potassium cyaniderespiration

0.214

NaN30.2-2 mM Sodium aziderespiration

0.734

Nigericin50 uM Nigericinrespiration

-0.590

TRC10-150 ug/mL Triclosanrespiration

0.040

TRZ10-25 ug/mL Thioridazinerespiration

1.344

Valinomycin0.5-10 uM Valinomycinrespiration

1.210

ZnSO42 mM ZnSO4respiration

2.243

menadione6-10 ug/mL Menadionerespiration

-0.039

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.176

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.055

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.062

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

2.430

NRP_1Non-replicating persistence stage 1dosRassociated

0.164

Amp0.2mg/mL AmpicillincellWall

0.202

Cephalexin20-100 ug/mL CephalexincellWall

0.623

Cerulenin0.32-5 ug/mL CerulenincellWall

0.236

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.208

EMB10-20 ug/mL EthambutolcellWall

0.493

Eta12-40 ug/mL EthionamidecellWall

0.918

INH0.2-0.4 ug/mL IsoniazidcellWall

0.152

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.108

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.019

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.726

BZA0.12 mg/mL BenzamidearomaticAmides

-0.922

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.063

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.615

H2O24 mM hydrogen peroxideDNAdamaging

0.166

Levo10 ug/mL LevofloxacinDNAdamaging

-0.315

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.521

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.752

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.030

UVUV-irradiationDNAdamaging

-0.644

ARP41-4 ug/mL Antitubercular compound ARP4?

0.142

Antimycin12.5-50 ug/mL Antimycin A?

0.214

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.073

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.005

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.092

PA8240.2-2 ug/mL PA-824?

-0.879

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.303

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.077

Verapamil50 uM Verapamil?

0.389

mercaptoethanol2 mM 2-Mercaptoethanol?

0.244

methoxatin10-20 ug/mL Methoxatin?